Antithrombin III human Withdrawn Phase 4 Trials for hereditary antithrombin III deficiency Supportive Care

IndicationsStatusPurposePhase
WithdrawnSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT02278575Atenativ Effect on Uterine Blood Flow and Preeclampsia